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births versus single births
1,

1

1

2

2

2

İkbal Seza PETRİÇLİ *, Caner KARA , Nihal DEMİREL , Dilek ULUBAŞ IŞIK , Ahmet Yağmur BAŞ
Department of Ophthalmology, Etlik Zübeyde Hanım Women’s Health Education and Research Hospital, Ankara, Turkey
2
Department of Neonatology, Etlik Zübeyde Hanım Women’s Health Education and Research Hospital, Ankara, Turkey
Received: 08.06.2017

Accepted/Published Online: 27.12.2017

Final Version: 23.02.2018

Background/aim: This study aimed to compare the incidence of any stage of retinopathy of prematurity (ROP) and type 1 ROP between
extremely preterm multiple- and single-birth infants.
Materials and methods: In this retrospective study, we included extremely preterm infants who were ≤27 weeks of gestational age at
birth. The screened infants were divided into two groups: single and multiple births. The incidence of any stage of ROP and type 1 ROP
was compared between the groups.
Results: This study included 301 infants; 225 were in the single-birth group and 76 were in multiple-birth group. The incidences of any
stage of ROP and type 1 ROP among all infants were 70.7% (213 of 301) and 16.6% (50 of 301), respectively. Regression analysis showed
that lower birth weight (OR = 0.99, P = 0.004) and longer length of stay in hospital (OR = 1.02, P = 0.002) were significantly correlated
with any stage of ROP. Compared to single-birth infants, the risk of any stage of ROP and type 1 ROP did not statistically increase for
multiple-birth infants (P > 0.05).
Conclusion: This study showed that multiple birth had no significant correlation with ROP development in extremely preterm infants.
Key words: Retinopathy of prematurity, extremely preterm infants, multiple birth

1. Introduction
Retinopathy of prematurity (ROP) is a vasoproliferative
disorder of the developing retina, which is an important
cause of childhood blindness and visual impairment in
developing countries (1). Continuous improvements
in neonatal intensive care have led to increased rates
of survival of extremely preterm infants in Turkey. As a
result, there are more extremely premature infants, who
are at risk of developing ROP (2). In Turkey, according
to results of screening performed in schools for visually
impaired children, ROP is currently the leading avoidable
and treatable cause of childhood blindness (3).
Over the past three decades, the rates of multiple births
have risen in many countries due to increases in ovulation
induction, in vitro fertilization, and childbearing at older
ages; this situation results in an increased number of
premature births (4–7). In many countries in the European
Union, approximately half of multiple-birth infants are
born preterm, and they account for 18%–25% of preterm
births in Europe (6). In Turkey, according to unpublished
data from the multicenter TR-ROP trial (clinicaltrials.gov,
* Correspondence: seza0906@yahoo.com

Identifier: NCT02814929), 28% of preterm infants who
were ≤32 weeks of gestational age (GA) at birth were from
multiple births.
There are conflicting results in the literature on multiple
birth as a risk factor for ROP development. Some studies
found that multiple birth is a risk factor for ROP (8–10);
however, this was not found in others (11–14).
The objective of the present study was to compare the
incidences of any stage of ROP and type 1 ROP between
multiple- and single-birth infants and to define whether
multiple birth is a risk factor for ROP development in
extremely preterm infants who are at the greatest risk for
ROP development.
2. Materials and methods
Records of infants from the Etlik Zübeyde Hanım Women’s
Health Training and Research Hospital, Department
of Ophthalmology, which is a reference center for the
diagnosis and treatment of ROP, were retrospectively
scanned. Preterm infants who were screened for ROP
between February 2010 and May 2016 with a GA of ≤27
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weeks at birth and inpatients at the neonatal intensive care
unit (NICU) were included in the study. Infants who were
referred from another center, who were lost to follow-up,
or who had a major systemic and/or eye abnormality were
excluded. GA, birth weight (BW), sex, single/multiplebirth status, ROP examination results, treatment type for
ROP if required, and postmenstrual age (PMA) at first
ROP development and type 1 ROP onset were recorded
from the files. Multiple-birth infants were defined as
infants born after pregnancies with two or more fetuses
simultaneously. The screened infants were divided into
two groups: single and multiple birth. The stage of ROP,
percentages of any stage of ROP and type 1 ROP, type of
treatment, and PMA at first ROP development and type 1
ROP onset were identified in both groups.
The first ROP screening examination was performed
at the 30th or 31st week of PMA in the NICU. PMA
was calculated by combining GA at birth and postnatal
age. Tropicamide 0.5% (Tropamid, Bilim, Turkey)
and phenylephrine 2.5% (Mydfrin, Alcon, USA) were
administered twice at an interval of 5 min at 1 h prior to
the examination for pupil dilatation. The examination was
performed under topical anesthesia with proparacaine HCl
drops (Alcaine 0.5%, Alcon, Belgium). The examinations
were performed using a lid speculum and scleral depressor
with an indirect binocular ophthalmoscope (Omega
2C, Heine, Germany) with a 20- or 28-diopter lens.
Findings were classified according to the International
Classification of Retinopathy of Prematurity (15).
Aggressive posterior AP-ROP was defined as severe plus
disease, flat neovascularization in zone 1 or posterior zone
2, intraretinal shunting, or hemorrhages (15). The followup examinations of the infants were scheduled based on
the persistence and severity of ROP.
Indications for treatment were for those whose retinopathy
met the criteria established by the Early Treatment for
Retinopathy of Prematurity study (16). According to these
criteria, included were infants with type 1 ROP (high-risk
prethreshold ROP), defined as zone I, any stage of ROP with
plus disease; zone I, stage 3 ROP without the plus disease; or
zone II, stage 2 or 3 with the plus disease. Treatments were
provided using either laser photocoagulation or intravitreal
bevacizumab injection (Avastin; Genentech Inc., South San
Francisco, CA, USA). Intravitreal bevacizumab injection was
performed in the eyes in which AP-ROP was detected. All
injection doses for bevacizumab were 0.625 mg (0.025 mL).
If the infants did not respond to intravitreal bevacizumab
injection or if ROP recurred, the patients were treated
further, using laser treatment. Other infants who met the
criteria for type 1 (high-risk prethreshold) ROP were treated
with transpupillary panretinal photocoagulation using an
810-nm diode laser (IRIDEX; OcuLight SLX, Mountain
View, CA, USA).
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This descriptive and retrospective study was conducted
in accordance with the principles of the Declaration of
Helsinki. The study was approved by the hospital’s ethics
committee.
Statistical analysis was performed using SPSS 21.0 for
Windows (IBM Corp., Armonk, NY, USA). Continuous
variables are presented as mean ± SD and categorical
variables are presented as number and percentage. The
chi-square test was used for categorical variables. After
normal distribution was evaluated using the Kolmogorov–
Smirnov and Shapiro–Wilk tests, the differences between
the means were analyzed by the t-test for normally
distributed data and the Mann–Whitney U test for
nonnormally distributed data. P < 0.05 was accepted as
being statistically significant.
Multivariate logistic regression analysis was performed
to evaluate the potential role of different risk factors
to predict any stage of ROP or type 1 ROP as a binary
outcome. For this purpose, variables such as BW, GA,
and length of stay in the hospital (which were statistically
significant in previous univariate logistic regression
analyses) were included in the model each time (less than
10% of the cases). The backward stepwise (likelihood
ratio) model was used for logistic regression analysis. The
Nagelkerke R square index was then used to compare the
strength of each model.
3. Results
Of the 449 extremely preterm infants identified from
the records, 148 who were referred to another NICU
for screening or for treating ROP were excluded. The
remaining 301 extremely premature infants (160 males,
53.2%; 141 females, 46.8%) were included in this study.
In the whole group, the overall mean BW was 970.90 ±
178.36 g (range: 540–1610 g) and the mean GA was 26.0 ±
1.0 weeks (range: 23–27 weeks).
The number of single-birth infants was 225 (74.8%)
and the number of multiple-birth infants was 76 (25.2%).
The multiple-birth group comprised 65 sets of twins
(85.5%), 6 sets (7.8%) of triplets, and 5 sets of (6.5%)
quintuplets. A comparison of the study groups according
to the mean GA, mean BW, mean length of hospital stay,
and sex is shown in Table 1. No statistical significance
was observed between the groups regarding sex, GA, BW,
and length of stay in hospital (Pearson chi-square test and
Mann–Whitney U test, P > 0.05).
The overall incidence of any stage of ROP and type 1
ROP was 70.7% (213 of 301 preterm infants) and 16.6%
(50 of 301 preterm infants), respectively. The mean PMA
at the onset of ROP and the development of type 1 ROP
in all infants was 32.4 ± 1.4 (range: 30–37) and 35.0 ± 1.7
(range: 32–40) weeks, respectively.
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Table 1. A comparison of the distribution of sex and mean gestational age, birth weight, and length of stay in hospital between the
groups.

Sex (n, %)
Gestational age (weeks)

Birth weight (g)
Length of stay in hospital (days)

Single-birth group
(n = 225)

Multiple-birth group
(n = 76)

Male

123 (54.7%)

37 (48.7%)

Female

102 (45.3%)

39 (51.3%)

Mean ± SD

26.0 ± 1.0

26.0 ± 1.0

Range

(23.0–27.0)

(23.0–27.0)

Mean ± SD

970.10 ± 182.47

971.01 ± 166.90

Range

(540–1610)

660–1320

Mean ± SD

79 ± 27

80 ± 23

Range

(27–184)

(14–147)

P-value
0.36*
0.19†
0.95†
0.44†

SD: Standard deviation,*: Pearson chi-square test, †: Mann–Whitney U test, n: number.

There was no difference between the groups in terms
of any stage of ROP and type 1 ROP. Furthermore, there
was no difference between the groups in terms of PMA
at ROP development and treatment. A comparison of the
distribution of any stage of ROP, type 1 ROP, treatment
type, and PMA at first ROP development and type 1 ROP
onset in the groups is shown in Table 2.
Logistic regression analysis of the 301 infants indicated
that lower BW (odds ratio (OR) = 0.99, 95% confidence
interval (CI): 0.99–0.99, P = 0.004) and longer length of

stay in hospital (OR = 1.02, 95% CI: 1.01–1.04, P = 0.002)
were significantly correlated with ROP while multiple
birth, sex, and GA had no significant effects. Logistic
regression analysis results for risk factors for type 1 ROP
revealed that only longer length of stay in the hospital
(OR = 1.03, 95% CI: 1.01–1.04, P = 0.001) was effective.
Multiple birth had no effects on the development of any
stage of ROP and type 1 ROP (any stage of ROP: OR =
1.69, 95% CI: 0.90–3.18, P = 0.10; type 1 ROP: OR = 0.70,
95% CI: 0.32–1.48, P = 0.35) (Table 3).

Table 2. A comparison of the distribution of any stage of ROP and type 1 ROP and the treatment type between the groups.

ROP (n, %)
PMA at ROP (weeks)
Type 1 ROP (n, %)
PMA at treatment (weeks)

Treatment type (n, %)

Single-birth group
(n = 225)

Multiple-birth group
(n = 76)

Yes

164 (72.9%)

49 (65.5%)

No

61 (27.1%)

27 (34.5%)

Mean ± SD

32 ± 1

33 ± 2

Range

(30–37)

(30–37)

Yes

36 (16.0%)

14 (18.4%)

No

189 (84.0%)

62 (81.6%)

Mean ± SD

35 ± 2

35 ± 2

Range

(32–40)

(32–38)

Laser

25 (11.1%)

11 (14.4%)

Anti-VEGF

8 (3.5%)

2 (2.6%)

Laser + Anti-VEGF

3 (1.3%)

1 (1.3%)

P-value
0.16*
0.67 †
0.62*
0.18 †

NA

*: Pearson chi-square test, ROP: retinopathy of prematurity, †: Mann–Whitney U test, n: number, PMA: postmenstrual age.
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Table 3. Logistic regression analysis results for risk factors for any stage of ROP and type 1 ROP.
Any stage of ROP

Type 1 ROP

P-value

OR

95% CI

P-value

OR

95% CI

Sex

0.414

1.26

0.71–2.24

0.065

1.99

0.95–4.16

Gestational age (weeks)

0.550

0.76

0.56–1.35

0.261

0.80

0.54–1.17

Birth weight (g)

0.004

0.99

0.99–0.99

0.097

0.99

0.99–1.00

Length of stay in hospital (days)

0.002

1.02

1.01–1.04

0.001

1.03

1.01–1.04

Multiple birth

0.100

1.69

0.90–3.18

0.353

0.70

0.32–1.48

ROP: Retinopathy of prematurity, OR: odds ratio, CI: confidence interval.

4. Discussion
This study investigated the incidence of any stage of ROP
and type 1 ROP in 301 extremely preterm infants who
were ≤27 weeks of GA at birth and who were born of
multiple and single births in the NICU at a single medical
center; no statistically significant difference was found
regarding the incidence and severity stage of ROP between
the groups. Controversies exist regarding the influence of
multiple birth on the development of ROP according to
the data presented in the literature. In a study conducted
by Motta et al. (10), the incidence of any stage of ROP was
higher in the multiple-birth group; there was no significant
difference between the single- and multiple-birth groups
regarding threshold disease rates. Sood et al. (9) concluded
that multiple birth might be an independent risk factor
for ROP development; however, they stated that further
studies, particularly with a higher number of multiplebirth infants, would yield more statistically reliable results.
In a Canadian study that compared data from 24 neonatal
clinics, the rate of severe ROP was lower in multiple-birth
infants than in single-birth infants (17).
Friling et al. (18) found that the incidence of ROP with
or without treatment requirement was statistically higher
in single-birth infants than in multiple-birth infants. In
their study groups, GA and BW were lower in single-birth
infants than in multiple-birth infants. In our study, the
groups were similar in terms of GA, BW, and length of stay
in hospital. Therefore, there was no significant difference
between the groups in terms of any stage of ROP and type
1 ROP.
Low BW and early GA are the main issues leading to
preterm morbidity rates in multiple births. Garite et al. (14)
showed that neonatal morbidities associated with adverse
long-term outcomes (intraventricular hemorrhage, ROP,
necrotizing enterocolitis) were not different between
multiple-birth infants and single-birth infants. Some
studies compared the incidence of ROP between multipleand single-birth infants and obtained similar results to
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ours (11–13). Friling et al. (12) showed that BW remains
the most important predictive factor for the development
of ROP. Riazi-Esfahani et al. (13) concluded that early GA
and low BW were the most important risk factors for ROP
development in single- and multiple-birth groups. In our
study, multivariate logistic regression analysis revealed
that lower BW and longer length of stay in hospital were
significantly correlated with ROP development; however,
multiple birth did not show any significant correlation.
The expectation of a quick outcome during the
application of assisted reproductive techniques increases
the risk of multiple birth (19). In Turkey, after single
embryo transfer was legally adopted with changes made to
the health policy from 2010, a significant decrease was seen
in the rate of multiple births and perinatal complications
(20,21). ROP is a major perinatal complication seen
in premature infants. Our study also included preterm
infants who were in the NICU in 2010 and after.
The present study showed that the overall incidences of
any stage of ROP and type 1 ROP were 70.7% and 16.6%,
respectively, in infants who were ≤27 weeks of GA at birth.
The incidence of type 1 ROP was higher in our study in
Turkey than in studies conducted in developed countries
such as Canada and the United States (22,23). In Turkey,
Baş et al. (2) reported that the incidence of any stage of
ROP was 52.8% and that of type 1 ROP was 15.1% in
extremely premature infants who were ≤28 weeks of GA
at birth in a multicenter ROP study. The incidence of ROP
was higher in our study, which can be explained as our
study was conducted among infants who were ≤27 weeks
of GA at birth. In Japan, Aikawa et al. (24) found that
the incidence of ROP was 70.6% and that of severe ROP
requiring laser treatment was 15.7% in extremely preterm
infants. These rates were similar to those in our study.
One of the main limitations of our study was the
inability to evaluate other systemic risk factors for
ROP development. However, we attempted to ensure
homogenization for perinatal care by excluding infants
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who were referred from external centers and including
those who had been monitored in the NICU. The fact that
the groups did not have equal numbers of infants may be
another limitation, but it was not possible to correct this
due to the low incidence of multiple births. However,
similar BWs, GAs, and lengths of stay in hospital between
the groups seem to a strength of our study.

In conclusion, to the best of our knowledge, this is
the first study on the effect of multiple birth on ROP in
extremely preterm infants. Compared to single-birth
infants, the risk of any stage of ROP and type 1 ROP did not
statistically increase in multiple-birth infants. However,
prospective studies on a larger number of infants in whom
perinatal risk factors are also evaluated could help clarify
the issue.
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